[Federal Register: May 10, 2004 (Volume 69, Number 90)]
[Notices]
[Page 25910-25911]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10my04-65]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Food Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committees: Food Advisory Committee, Dietary Supplements
Subcommittee of the Food Advisory Committee and Contaminants and
Natural Toxicants Subcommittee of the Food Advisory Committee. The Food
Advisory Committee and its Dietary Supplements subcommittee will meet
for the first portion of the meeting; the Food Advisory Committee and
its Contaminants and Natural Toxicants subcommittee will meet for the
second portion of the meeting.
General Function of the Committees: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: This meeting will have two parts. The first portion
of the meeting will be the Food Advisory Committee and its Dietary
Supplements Subcommittee and will be held on June 7, 2004, from 8 a.m.
until 5 p.m.; and on June 8, 2004, from 8 a.m. until 1:45 p.m.
The second portion of the meeting will be the Food Advisory
Committee and its Contaminants and Natural Toxicants Subcommittee and
will be held on June 8, 2004, from 2 p.m. until 6 p.m.
Location: Bethesda Marriott, Grand Ballroom, 5150 Pooks Hill Rd.,
Bethesda, MD.
Contact Person: Linda L. Reed, Center for Food Safety and Applied
Nutrition (HFS-006), Food and Drug Administration, 5100 Paint Branch
Pkwy., College Park, MD, 301-436-2397, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code 3014510564. Please call the Information Line for up-to-date
information on this meeting.
Agenda: FDA has received health claim petitions concerning the
following topics: (1) Glucosamine and chondroitin sulfate and
osteoarthritis, and (2) crystalline glucosamine sulfate and
osteoarthritis. The purpose of the portion of the meeting of the Food
Advisory Committee and its Dietary Supplements Subcommittee is to
gather information and to receive advice and recommendations relating
to the etiology of osteoarthritis, its modifiable risk factors, and the
relevance of scientific studies cited in the petitions to
substantiating the substance-disease relationship.
The purpose of the portion of the meeting of the Food Advisory
Committee and its Contaminants and Natural Toxicants Subcommittee is to
discuss data needs pertaining to the evaluation of furan, a chemical
formed during thermal treatments of food. Elsewhere in this issue of
the Federal Register, FDA is publishing a notice that requests the
submission of data and information pertaining to the occurrence of
furan in food, its mechanism of formation as well as its mechanism of
toxicity.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by May 24, 2004.
[[Page 25911]]
For the portion of the meeting of the Food Advisory Committee and
its Dietary Supplements Subcommittee, oral presentations from the
public will be scheduled between approximately 3:30 p.m. and 5 p.m. on
June 7, 2004.
For the portion of the meeting of the Food Advisory Committee and
its Contaminants and Natural Toxicants subcommittee, oral presentations
from the public will be scheduled between approximately 4 p.m. and 5
p.m. on June 8, 2004.
Time allotted for each presentation may be limited. Those desiring
to make formal oral presentations should notify the contact person
before May 24, 2004, and submit a brief statement of the general nature
of the evidence or arguments they wish to present, the names and
addresses of proposed participants, the specific portion of the meeting
at which they wish to present, and an indication of the approximate
time requested to make their presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Linda Reed at least
7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: April 29, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-10589 Filed 5-7-04; 8:45 am]
BILLING CODE 4160-01-S